For its first fiscal quarter (ending March 31), Royal Gold Inc (NASDAQ: RGLD) has reported a -26% decline in E.P.S. from $0.97 a year ago to $0.72 in the current quarter. This performance was $-0.74 […]
R1 RCM INC (NASDAQ: RCM) has reported E.P.S. of $-0.08 for its first fiscal quarter (ending March 31) versus $0.00 for the same period a year ago. For the latest four quarters through March 31, […]
QuidelOrtho Corporation (NASDAQ: QDEL) has reported a loss for its first fiscal quarter (ending March 31) of $-25.50 versus $0.73 for the same period a year ago — a decline of -3593%. This result fell […]
Prospect Capital Corp (NASDAQ: PSEC) has reported earnings for its third fiscal quarter (ending March 31) of $0.27 versus a loss $-0.27 for the same period a year ago. This result exceeded the consensus estimate […]
On 5/8/24, Pacira BioSciences Inc (NASDAQ: PCRX) stock enjoyed a major increase of 11.8%, closing at $29.65. Moreover, exceptionally high trading volume at 386% of normal accompanied the advance. The stock has risen 13.0% during […]
Origin Agritech Ltd (NASDAQ: SEED) stock closed at $4.34 on 5/8/24 after a major increase of 26.7%. Moreover, trading volume in this advance was exceptionally high at 842% of normal. The stock has risen 31.1% […]
Nu Skin Enterprises Inc. (NYSE: NUS) has reported a loss for its first fiscal quarter (ending March 31) of $-0.01 versus $0.23 for the same period a year ago — a decline of -104%. This […]
NiSource Inc (NYSE: NI) has reported earnings for its first fiscal quarter (ending March 31) of $0.77 versus $0.77 for the same period a year ago — flat performance. This result fell short of the […]
For its first fiscal quarter (ending March 31), NV5 Global Inc (NASDAQ: NVEE) has reported a -92% decline in E.P.S. from $0.40 a year ago to $0.03 in the current quarter. This performance was $-0.98 […]
Masimo Corp (NASDAQ: MASI) stock closed at $120.02 on 5/8/24 after a major decline of -11.8%. Moreover, this decline was accompanied by exceptionally high trading volume at 430% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research